Astera Labs, Inc. $ALAB Holdings Raised by Value Aligned Research Advisors LLC

Value Aligned Research Advisors LLC lifted its position in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 16.7% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,378,351 shares of the company’s stock after acquiring an additional 197,320 shares during the period. Astera Labs comprises approximately 3.3% of Value Aligned Research Advisors LLC’s holdings, making the stock its 12th largest holding. Value Aligned Research Advisors LLC owned about 0.82% of Astera Labs worth $269,881,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the company. Geneva Partners LLC acquired a new stake in shares of Astera Labs during the 3rd quarter worth approximately $1,876,000. Numerai GP LLC boosted its position in Astera Labs by 153.1% during the 3rd quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock valued at $2,587,000 after purchasing an additional 7,992 shares during the period. Handelsbanken Fonder AB boosted its position in Astera Labs by 289.5% during the 3rd quarter. Handelsbanken Fonder AB now owns 126,200 shares of the company’s stock valued at $24,710,000 after purchasing an additional 93,800 shares during the period. Corient Private Wealth LLC bought a new position in Astera Labs during the 2nd quarter worth $543,000. Finally, Paragon Advisors LLC acquired a new stake in Astera Labs in the third quarter worth $1,829,000. 60.47% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Astera Labs

In related news, COO Sanjay Gajendra sold 94,971 shares of the business’s stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total transaction of $11,758,359.51. Following the sale, the chief operating officer owned 1,531,301 shares of the company’s stock, valued at $189,590,376.81. The trade was a 5.84% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Jitendra Mohan sold 94,971 shares of the company’s stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total value of $11,758,359.51. Following the completion of the sale, the chief executive officer owned 1,452,739 shares of the company’s stock, valued at $179,863,615.59. This trade represents a 6.14% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 226,792 shares of company stock valued at $28,001,069. 12.50% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on the company. Loop Capital started coverage on Astera Labs in a research note on Thursday, March 5th. They issued a “buy” rating and a $250.00 target price on the stock. Weiss Ratings cut shares of Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, February 23rd. Morgan Stanley reaffirmed an “overweight” rating and issued a $210.00 price objective on shares of Astera Labs in a report on Wednesday, December 3rd. Northland Securities lifted their price objective on shares of Astera Labs from $175.00 to $195.00 and gave the company an “outperform” rating in a research report on Tuesday, December 9th. Finally, Raymond James Financial started coverage on shares of Astera Labs in a research report on Friday, November 21st. They issued a “hold” rating for the company. Fifteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Astera Labs has an average rating of “Moderate Buy” and an average price target of $202.22.

Astera Labs Stock Down 1.0%

ALAB stock opened at $126.34 on Thursday. The company has a 50-day simple moving average of $145.64 and a 200 day simple moving average of $166.93. The company has a market capitalization of $21.50 billion, a P/E ratio of 103.56, a PEG ratio of 2.51 and a beta of 1.74. Astera Labs, Inc. has a fifty-two week low of $47.13 and a fifty-two week high of $262.90.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, topping analysts’ consensus estimates of $0.51 by $0.07. The company had revenue of $270.58 million for the quarter, compared to the consensus estimate of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. Astera Labs’s revenue was up 91.8% on a year-over-year basis. During the same period in the previous year, the firm earned $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Equities analysts anticipate that Astera Labs, Inc. will post 0.34 EPS for the current year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.